Vinati Organics Q1FY27: Revenue +28%, PAT ₹109cr

Key takeaways from the quarter

Vinati Organics Limited reported a strong jump in sales for the quarter ended June 30, 2026 (Q1FY27), while profit growth remained modest. Consolidated revenue from operations rose 28.4% year-on-year to ₹695.91 crore. Consolidated net profit increased 4.5% year-on-year to ₹108.86 crore, with earnings per share (EPS) at ₹10.50 versus ₹10.05 a year ago. On a standalone basis, net profit rose 9.6% to ₹123.56 crore and revenue increased 28.7% to ₹697.75 crore. The company’s board approved the unaudited standalone and consolidated results on July 29, 2026. The numbers point to a quarter where top-line momentum improved meaningfully, but profitability margins moderated compared with the prior-year quarter.

Board approval and statutory review details

The company said its Board of Directors met on July 29, 2026 and unanimously approved the unaudited financial results for Q1FY27. The results were reviewed by the statutory auditors, M/s M. M. Nissim & Co. LLP, under a limited review. The auditors issued limited review reports dated July 29, 2026 and reported that nothing came to their attention to suggest the statements do not comply with applicable accounting standards or contain material misstatement. The disclosures were made under SEBI Listing Regulations. Vinati Organics also stated the results were uploaded on the company’s website and made available on BSE and NSE websites. The results were published in Business Standard and Sakal on July 30, 2026, in line with Regulation 47.

Consolidated performance: revenue surge, profit growth slower

For Q1FY27, consolidated total income was ₹704.91 crore, while total consolidated expenses were ₹557.15 crore. Consolidated profit before tax (PBT) came in at ₹147.76 crore compared with ₹141.16 crore in Q1FY26. Tax expense included current tax of ₹35.16 crore and deferred tax of ₹3.74 crore, resulting in consolidated profit from continuing operations of ₹108.85 crore to ₹108.86 crore (as reported across disclosures). The company also reported that no exceptional items were recorded in either standalone or consolidated statements for the quarter. Separately reported figures indicated a sequential decline in consolidated profit versus Q4FY26, where PAT was ₹123.86 crore. Revenue also increased sequentially, with Q1FY27 revenue from operations at ₹695.91 crore versus ₹603.92 crore in Q4FY26.

Standalone performance: higher PAT and PBT

On a standalone basis, total income for the quarter was ₹706.60 crore, comprising revenue from operations and other income. Total expenses were ₹541.70 crore, resulting in standalone PBT of ₹164.90 crore compared with ₹151.47 crore in Q1FY26. The tax expense comprised current tax of ₹34.67 crore and deferred tax of ₹6.47 crore. Standalone profit for the period from continuing operations was ₹123.56 crore, up from ₹112.78 crore in Q1FY26. Standalone EPS (basic and diluted) was ₹11.92 compared with ₹10.88 in the year-ago quarter. The company also disclosed that standalone cost of materials consumed rose to ₹362.11 crore from ₹282.29 crore, indicating higher raw material input costs.

Margins and cost pressures highlighted in the filings

Alongside revenue growth, disclosures pointed to margin compression during the quarter. One set of figures put consolidated EBITDA at ₹170.49 crore with an operating margin of 24.5%, compared with 29.5% in Q1FY26 and 29.5% in Q4FY26. Consolidated net margin was stated at 15.6%, versus 18.7% in Q1FY26 and 20.3% in Q4FY26. Expense lines cited for Q1FY27 included cost of materials consumed at ₹380.62 crore, employee benefits at ₹50.46 crore, power and fuel at ₹49.43 crore, other expenditure at ₹49.58 crore, and depreciation at ₹31.72 crore, while finance costs were negligible at ₹0.01 crore. The overall picture presented was that higher costs, especially raw materials, limited the conversion of strong revenue growth into faster profit growth.

Snapshot table: Q1FY27 vs Q1FY26

Subsidiary and group disclosures

The company disclosed that its foreign subsidiary, Vinati Organics USA INC, reported total revenues of ₹5.96 crore and net profit of ₹0.91 crore for the quarter ended June 30, 2026. These figures were stated as not reviewed by the auditors, but certified by management as not material to the group. This disclosure is relevant for investors tracking group-level performance, particularly where smaller overseas units can affect reported consolidated numbers. The consolidated statements also carried the usual reporting on income, expenses, and profit for continuing operations for the quarter.

Balance sheet and capital position

Vinati Organics reported reserves (excluding revaluation reserve) of ₹3,151.31 crore as on March 31, 2026. The company maintained a paid-up equity share capital of ₹10.37 crore (face value ₹1 per share), unchanged from prior periods shown in the filing. It also disclosed that it remains debt-free as of March 31, 2026, with net debt stated as nil in a results snapshot. The company also cited a treasury of ₹190 crore in current investments to fund planned capital expenditure. These balance sheet disclosures help frame how Vinati Organics is positioned to fund expansion while absorbing quarter-to-quarter volatility in margins.

Guidance and Veeral Organics timeline

Vinati Organics guided for approximately 15% volume growth in FY27. It also discussed expectations from subsidiary Veeral Organics Pvt. Ltd., stating revenue contribution is expected to begin from Q3FY27 onwards, with production scheduled to resume in October 2026 following necessary process reengineering. In another disclosure, the company said Veeral Organics is expected to contribute revenues of ₹400-500 crore, with the business commencing operations in March 2027 at an estimated revenue of ₹150 crore. The company also stated a long-term EBITDA margin range it considers reasonably achievable at 26% to 27%. Separately, it noted that while management targets 15% to 20% volume growth for ATBS in FY27, the antioxidants segment remains under pressure from aggressive Chinese pricing, with only 5% growth recorded in the previous fiscal year.

Market snapshot and what investors watched

The disclosures included a market snapshot with a reported market capitalisation of ₹13,393.57 crore and a quoted price around ₹1,292.0, while another figure cited was ₹1,298.50. While the quarter delivered record-level revenue in some summaries, the key investor focus remained the gap between revenue growth and profit growth. Sequentially, consolidated PAT was reported lower than Q4FY26 (₹123.86 crore), indicating weaker profitability versus the immediately preceding quarter. At the same time, management commentary across disclosures pointed to input-cost pressure as a factor to monitor. For the near term, investors are likely to track whether margins stabilise as revenue growth continues and as Veeral Organics moves through its stated restart and commencement timeline.

Conclusion

Vinati Organics’ Q1FY27 results showed strong year-on-year revenue growth, with consolidated revenue rising to ₹695.91 crore and consolidated net profit increasing to ₹108.86 crore. The board approval on July 29, 2026 and the unmodified limited review reports provided regulatory and audit comfort on the reported numbers. However, the quarter also reflected margin compression, with costs rising alongside volumes and sales. The next set of updates investors will watch are management’s progress on FY27 volume guidance and the timeline for Veeral Organics, including the stated October 2026 production resumption plan and the March 2027 commencement expectation mentioned in disclosures.